Background: Macrolides are recommended as an adjunctive treatment for patients with
moderate to severe chronic obstructive pulmonary disease (COPD) who experience …

Background: Chronic obstructive pulmonary disease (COPD) is currently the fourth largest
fatal disease in the world, and is expected to rise to third place by 2020. Frequent acute …

Background: Chronic obstructive pulmonary disease (COPD) is a prevalent condition with
fewer treatments available as the severity increases. Previous systematic reviews have …

First, it is not clear how dual diagnosis individuals were handled. There is very little known
about individuals with both an asthma and a COPD diagnosis. The percent of individuals …

Prevention of COPD exacerbations is paramount given the adverse consequences on
quality of life, lung function, and survival. Macrolide therapy for 1 year, in addition to usual …

Background: Macrolide antibiotics have anti-inflammatory effects, and long-term
administration may reduce chronic obstructive pulmonary disease (COPD) exacerbations …

Exacerbations of chronic obstructive pul monary disease (COPD) are character ized by
worsening respiratory symp toms, which are almost always accompanied by an increase in …

Background Acute exacerbation of COPD (AECOPD) is associated with an increased
hospitalization and mortality. Azithromycin and erythromycin are the recommended drugs to …

Chronic obstructive pulmonary disease is a condition of growing global importance, in the
UK alone it affects at least 3 million people, and it is thought that less than a third of these …

Several studies and meta-analyses have recently shown a positive effect of maintenance
treatment with macrolide antibiotics in patients with chronic obstructive pulmonary disease …